Advertisement
Singapore markets closed
  • Straits Times Index

    3,176.51
    -11.15 (-0.35%)
     
  • Nikkei

    37,068.35
    -1,011.35 (-2.66%)
     
  • Hang Seng

    16,224.14
    -161.73 (-0.99%)
     
  • FTSE 100

    7,844.18
    -32.87 (-0.42%)
     
  • Bitcoin USD

    64,832.98
    +2,605.73 (+4.19%)
     
  • CMC Crypto 200

    1,335.89
    +23.27 (+1.81%)
     
  • S&P 500

    5,011.12
    -11.09 (-0.22%)
     
  • Dow

    37,775.38
    +22.07 (+0.06%)
     
  • Nasdaq

    15,601.50
    -81.87 (-0.52%)
     
  • Gold

    2,395.50
    -2.50 (-0.10%)
     
  • Crude Oil

    82.24
    -0.49 (-0.59%)
     
  • 10-Yr Bond

    4.6020
    -0.0450 (-0.97%)
     
  • FTSE Bursa Malaysia

    1,547.57
    +2.81 (+0.18%)
     
  • Jakarta Composite Index

    7,087.32
    -79.50 (-1.11%)
     
  • PSE Index

    6,443.00
    -80.19 (-1.23%)
     

Why Compass Pathways Is Soaring Today

Why Compass Pathways Is Soaring Today

Last Friday, U.K.-based Compass Pathways (NASDAQ: CMPS) became the first psychedelic medicine company to go public on a major U.S. exchange. The drugmaker's shares promptly rose by an eye-catching 70.5% during their first day of trading on the Nasdaq stock exchange. Compass' upward momentum, following this historic public debut, appears set to continue today, with the drugmaker's shares up by 10.8% in pre-market action Monday morning.